Providence, a prominent not-for-profit Catholic healthcare system, has unveiled the launch of Praia Health, a cutting-edge consumer platform for healthcare systems, in conjunction with securing a million oversubscribed Series A funding round. Frist Cressey Ventures spearheaded the round, with contributions from Epsilon Health Investors, Providence Ventures, and SignalFire.
Navid Farzad, partner at Frist Cressey, and Sara Vaezy, Providence’s chief strategy and digital officer, have joined the board of directors of the newly established company. Yuanling Yuan from SignalFire and Justin Dearborn, Praia Health’s CEO, have also been appointed to the board.
Praia Health functions as a consumer platform for health systems, offering a low-code ecosystem to facilitate the seamless integration of third-party consumer offerings into a health system’s digital experience. The company handles the data exchange between the health system’s electronic medical record platform, other data sources, and the digital health solution.
With seventeen digital health partners in its ecosystem, including Wellthy, Omada Health, and Wildflower Health, Praia Health has already made its mark in the industry. This initiative is the fourth technology incubated by Providence Digital Innovation Group, an innovation center within Providence.
“Partnerships and cross-industry collaboration are crucial for health systems, and an open, efficient platform for data sharing and consumer engagement is essential,” stated Dearborn. “Streamlining the delivery of consumer-facing solutions benefits both operational efficiency and patient satisfaction.”
In the rapidly evolving healthcare landscape, numerous healthcare systems have embarked on spinouts to expand the digital health ecosystem. For example, Mount Sinai Health launched Sema4, a spinout focused on developing health data analytics platforms. Boston Children’s Hospital has also introduced Mightier, a spinout that produces biofeedback video games to aid children in emotional regulation. Similarly, Johns Hopkins and Mount Sinai Health System have launched Vixiar, a tablet-based cardiac assessment system, and OOVA, which concentrates on fertility and women’s health, respectively.
